13th International Congress of TDM & Clinical Toxicology
September 22 – 26, 2013
Salt Lake City, USA

12th International Congress of TDM & Clinical Toxicology
October 2 - 6, 2011
Stuttgart Germany
View photos from the Congress!

Foster and promote education and research in therapeutic drug monitoring and clinical toxicology;

Improve the standards of practice and clinical interpretation of drug and toxic substance analyses and facilitate the delivery of interpretation through clinical pharmacokinetics and toxicokinetics for enhanced patient care;

Encourage cooperation with and among members of all professions concerned with TDM and clinical toxicology;

Encourage the effective application of therapeutic drug monitoring to optimize clinical drug use and maximize the clinical and economic benefits;

Encourage progress in clinical toxicology as a diagnostic tool and therapeutic aid for therapeutic drug overdoses, drug abuse, and exposure to environmental toxicants.

Application form (PDF)

Definition of TDM

IATDMCT Needs You! - Click here!

Therapeutic Drug Monitoring is the official journal of IATDMCT

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Instructions for authors

Clinical Toxicology/Drugs of Abuse Committee

Updated February 2013

Chair	Professor Dr. Olaf Drummer	olaf@vifm.org
Vice-Chair	Dr Vanessa Steenkamp	vanessa.steenkamp@up.ac.za

Background/Purpose of the Committee

To promote and advance the discipline of Clinical Toxicology within the Association by:

Developing relevant practice guidelines, when appropriate, in particular fields of clinical toxicology and drugs of abuse testing;
Publishing articles and other professional notes in the field of clinical toxicology and drugs of abuse in the Newsletter and on the web page;
Assist in the holding of specialist workshops and symposia at the biennial Association meetings;
Developing links and partnerships with other relevant professional societies; and
Attracting new members to the Association with interests in clinical toxicology and drugs of abuse.

Committee Initiatives for 2013/2015

Papers being prepared on Gamma-hydroxy-butyrate (GHB) (Drummer and Scholer) and methyl phenidate (Scholer) for Compass
Sub-committee established to prepare mass spectrometry identification guidelines, chaired by Dr Frank Peters – report will follow with recommendations

Members

Members who would like to get actively involved in one of these projects or other members who would like to propose new projects are warmly welcome to send an email to (t.vangelder@erasmusmc.nl) Teun van Gelder.

Name	Position	Country	Email
Professor Dr. Albert Fraser	Member	Canada	adfraser@dal.ca
Professor Dr. Marilyn A. Huestis	Member	USA	mhuestis@intra.nida.nih.gov
Dr. Saeed A. Jortani	Member	USA	sjortani@Louisville.edu
Dr. Pascal Kintz	Member	France	pascal.kintz@wanadoo.fr
Professor Dr. Tai C. Kwong	Member	USA	tai_kwong@urmc.rochester.edu
Professor Dr. Hans H. Maurer	Member	Germany	hans.maurer@uks.eu
Dr. Katharina Rentsch	Member	Switzerland	rentsch@ikc.unizh.ch
Dr. André Scholer	Member	Switzerland	andrescholer@intergga.ch
Professor Dr. Donald Uges	Member	Netherlands	d.r.a.uges@umcg.nl
Professor Dr. Alain Verstraete	Member	Belgium	Alain.Verstraete@ugent.be
Dr. John F. Wilson	Member	UK	heathcontrol@btinternet.com
Professor Dr. Steven Wong	Member	USA	shwong@wakehealth.edu
Dr. Loralie Langman	Member	USA	langman.loralie@mayo.edu
Dr. Frank Peters	Member	Germany	frank.peters@med.uni-jena.de
Dr. William Clarke	Member	USA	wclarke@jhmi.edu
Dr. Gwendolyn McMillin	Member	USA	gwen.mcmillin@aruplab.com
Dr. Manuela Neuman	Member	Canada	manuela.neuman@utoronto.ca

Members Only

Events

Login

Our aims are:

Journal

Clinical Toxicology/Drugs of Abuse Committee